Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multicenter, placebo controlled, randomized, double blind, subject initiated study of the safety and efficacy of the electrokinetic transdermal system (ETS) with acyclovir gel for the episodic treatment of herpes labialis

Next Previous
Trial Profile

A multicenter, placebo controlled, randomized, double blind, subject initiated study of the safety and efficacy of the electrokinetic transdermal system (ETS) with acyclovir gel for the episodic treatment of herpes labialis

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 14 Feb 2008

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Aciclovir (Primary)
  • Indications Herpes labialis
  • Focus Therapeutic Use
  • Sponsors Transport Pharmaceuticals

Most Recent Events

  • 01 Feb 2008 Status change from in progress to completed as reported by clinicaltrials.gov.
  • 27 Aug 2007 Status changed from recruiting to in progress.
  • 12 Feb 2007 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top